文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

HIV 病毒载量升高后病毒抑制的恢复:系统评价和荟萃分析。

HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis.

机构信息

Department of HIV, World Health Organization, Geneva, Switzerland.

Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

出版信息

J Int AIDS Soc. 2019 Nov;22(11):e25415. doi: 10.1002/jia2.25415.


DOI:10.1002/jia2.25415
PMID:31746541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6864498/
Abstract

INTRODUCTION: Guidelines for antiretroviral therapy recommend enhanced adherence counselling be provided to individuals with an initial elevated viral load before making a decision whether to switch antiretroviral regimen. We undertook this systematic review to estimate the proportion of patients with an initial elevated viral load who resuppress following enhanced adherence counselling. METHODS: Two databases and two conference abstract sites were searched from January 2012 to October 2019 for studies reporting the number of patients with an elevated viral load whose viral load was undetectable when subsequently assessed. Data were pooled using random effects meta-analysis. RESULTS: Fifty-eight studies reported outcomes of 45,720 viraemic patients, mostly from Africa (48 studies), and among patients on first-line antiretroviral therapy (43 studies). Almost half (46.1%, 95% CI 42.6% to 49.5%) of patients with an initial elevated viral load resuppressed following an enhanced adherence intervention. Of those on first-line ART with confirmed virological failure (6280 patients, 21 studies), only 53.4% (40.1% to 66.8%) were appropriately switched to a different regimen. Resuppression was higher among studies that provided details of adherence support. The proportion resuppressing was lower among children (31.2%, 21.1% to 41.3%) and adolescents (40.4%, 15.7% to 65.2%) compared to adults (50.4%, 42.6% to 58.3%). No important differences were observed by date of study publication, gender, viral failure threshold, publication status, time between viral loads or treatment regimen. Information on resistance testing among people with an elevated viral load was inconsistently reported. CONCLUSIONS: The findings of this review suggest that in settings with limited resources, current guideline recommendations to provide enhanced adherence counselling can result in resuppression of a substantial number of these patients, avoiding unnecessary drug regimen changes. Appropriate action on viral load results is limited across a range of settings, highlighting the importance of viral load cascade analyses to identify gaps and focus quality improvement to ensure that action is taken on the results of viral load testing.

摘要

简介:抗逆转录病毒治疗指南建议,在决定是否更换抗逆转录病毒方案之前,应对初始病毒载量升高的个体提供强化依从性咨询。我们进行了这项系统评价,以估计初始病毒载量升高的患者在接受强化依从性咨询后病毒载量得到抑制的比例。

方法:从 2012 年 1 月至 2019 年 10 月,我们在两个数据库和两个会议摘要网站上搜索了报告初始病毒载量升高的患者数量的研究,这些患者的病毒载量在随后的评估中不可检测。使用随机效应荟萃分析对数据进行了汇总。

结果:58 项研究报告了 45720 名病毒血症患者的结局,这些研究大多来自非洲(48 项研究),并且是在一线抗逆转录病毒治疗中(43 项研究)。初始病毒载量升高的患者中,有近一半(46.1%,95%CI 42.6%至 49.5%)在接受强化依从性干预后病毒载量得到抑制。在有明确病毒学失败的一线 ART 患者(6280 名患者,21 项研究)中,只有 53.4%(40.1%至 66.8%)被适当转换为不同的方案。提供详细的依从性支持的研究中,病毒载量抑制的比例更高。与成年人(50.4%,42.6%至 58.3%)相比,儿童(31.2%,21.1%至 41.3%)和青少年(40.4%,15.7%至 65.2%)病毒载量抑制的比例较低。研究发表日期、性别、病毒失败阈值、发表状态、病毒载量检测之间的时间、治疗方案等因素均未观察到重要差异。关于病毒载量升高患者的耐药检测信息报告不一致。

结论:本综述结果表明,在资源有限的环境中,目前的指南建议提供强化依从性咨询,可以使大量患者的病毒载量得到抑制,避免不必要的药物方案改变。在一系列环境中,对病毒载量结果的适当处理受到限制,突出了病毒载量级联分析的重要性,以发现差距并集中质量改进,以确保对病毒载量检测结果采取行动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5919/6864498/8fb9c9fc49d2/JIA2-22-e25415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5919/6864498/05d137c455d2/JIA2-22-e25415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5919/6864498/8fb9c9fc49d2/JIA2-22-e25415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5919/6864498/05d137c455d2/JIA2-22-e25415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5919/6864498/8fb9c9fc49d2/JIA2-22-e25415-g002.jpg

相似文献

[1]
HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis.

J Int AIDS Soc. 2019-11

[2]
Outcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort study.

Lancet HIV. 2015-4

[3]
Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure.

J Acquir Immune Defic Syndr. 2017-10-1

[4]
Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.

Trop Med Int Health. 2016-9

[5]
High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania.

Trop Med Int Health. 2020-2-6

[6]
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.

Lancet HIV. 2019-10-7

[7]
When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a .

J Int AIDS Soc. 2017-7-19

[8]
Viral load monitoring as a tool to reinforce adherence: a systematic review.

J Acquir Immune Defic Syndr. 2013-9-1

[9]
SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.

BMC Infect Dis. 2018-2-12

[10]
Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Cochrane Database Syst Rev. 2010-4-14

引用本文的文献

[1]
Confronting Dual Therapeutic Hurdles in Advanced HIV: A Case Report on INSTIs Resistance and Talaromyces marneffei Coinfection.

Int Med Case Rep J. 2025-8-22

[2]
Acceptability and feasibility of a mobile electronic medical record system for community-based antiretroviral therapy in Lilongwe, Malawi: A rapid qualitative analysis.

PLoS One. 2025-5-23

[3]
Feasibility of smartphone-enabled asynchronous video directly observed therapy to improve viral suppression outcomes among HIV unsuppressed children and adolescents in Kenya.

BMC Infect Dis. 2025-4-30

[4]
Modeling the potential impact of viral load monitoring on vertical transmission of HIV in Kenya.

AIDS. 2025-7-15

[5]
Determinants of HIV viral load suppression rates in Amhara region, Ethiopia with a large number of internally displaced people.

J Migr Health. 2025-2-11

[6]
Factors associated with viral load re-suppression after enhanced adherence counseling among people living with HIV with an initial high viral load result in selected Nigerian states.

PLOS Glob Public Health. 2024-11-22

[7]
Factors associated with completion of intensive adherence counseling among people living with HIV at a large referral hospital in Uganda: a retrospective analysis.

BMC Health Serv Res. 2024-9-19

[8]
Adherence of healthcare providers to Enhanced Adherence Counseling (EAC) intervention protocol in West Amhara Public Health Facilities, Northwest Ethiopia, 2023: mixed method evaluation.

BMC Infect Dis. 2024-9-13

[9]
Predictors of HIV Viral Load Suppression After Enhanced Adherence Counseling, Nekemte, Ethiopia.

J Epidemiol Glob Health. 2024-9

[10]
Viral load suppression and its predictor among HIV seropositive people who receive enhanced adherence counseling at public health institutions in Bahir Dar, Northwest Ethiopia. Retrospective follow-up study.

PLoS One. 2024

本文引用的文献

[1]
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.

Lancet HIV. 2019-10-7

[2]
The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho.

PLoS One. 2019-8-28

[3]
Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure.

AIDS. 2019-8-1

[4]
Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues.

PLoS One. 2019-2-5

[5]
Viral load detection and management on first line ART in rural Rwanda.

BMC Infect Dis. 2019-1-3

[6]
Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland.

J Int AIDS Soc. 2018-10

[7]
Effectiveness of interventions for unstable patients on antiretroviral therapy in South Africa: results of a cluster-randomised evaluation.

Trop Med Int Health. 2018-10-24

[8]
Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda.

BMC Public Health. 2018-8-22

[9]
The Treatment Cascade in Children With Unsuppressed Viral Load-A Reality Check in Rural Lesotho, Southern Africa.

J Acquir Immune Defic Syndr. 2018-3-1

[10]
When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a .

J Int AIDS Soc. 2017-7-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索